BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, March 28, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 27, 2021
View Archived Issues
Tetracyclines may help in mitochondrial disease
Read More
BioVaxys announces advances in its vaccine platforms
Read More
TLR2/6 activation using INNA-051 shows promise as prophylactic strategy against COVID-19
Read More
Model reveals key role of LGI1-ADAM22-MAGUK complex in transsynaptic nanoarchitecture
Read More
Enrollment begins in first-in-human trial of BI-1808 in solid tumors and CTCL
Read More
Vir releases initial phase I data for its HBV-neutralizing monoclonal antibody, VIR-3434
Read More
Keytruda approved in Europe as first-line treatment of metastatic MSI-H or dMMR colorectal cancer
Read More
First patients dosed in phase II study of GS-248 in systemic sclerosis
Read More
Incyte divulges FGFR-3 inhibitors
Read More
Medshine Discovery patents new PORCN inhibitors
Read More
Positive interim data from phase III prevention trial of REGEN-COV
Read More
Boragen presents new tyrosine kinase inhibitors
Read More
Qilu Regor Therapeutics patent details MAP4K1 inhibitors
Read More
New CDK inhibitors patented by Nuvation Bio
Read More
Microbial tyrosine metabolism protects against asthma
Read More
BLAZE-1 study of bamlanivimab plus etesevimab meets primary endpoint in high-risk COVID-19
Read More
OS Therapies receives approval for its phase IIb study of OST-HER2 in osteosarcoma
Read More
PARP inhibitor stenoparib shows activity against SARS-CoV-2
Read More
Rhythm presents positive clinical data and development update for setmelanotide
Read More
FDA approves phase II/III HIBISCUS trial of traumakine in patients with COVID-19
Read More
FDA allows Cardif Oncology to proceed with phase II trial of onvansertib in PDAC
Read More
Sorrento reports preliminary phase Ib results on COVI-MSC for COVID-19
Read More
Primary endpoint met in ACTIVATE-T trial of mitapivat in transfused patients with PK deficiency
Read More
Syndesi reports phase I data on SV2A modulator SDI-118
Read More
DPP-4 inhibitor sitagliptin prevents incidence of GvHD after allogeneic HSCT in AML
Read More
BriaCell reports data from monotherapy and combination therapy studies of Bria-IMT
Read More
FDA clears IND for anti-4-1BB therapeutic monoclonal antibody EU-101
Read More
NIAID reports phase IIb results on VRC-01 for HIV prevention
Read More
